Cargando…

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole

Cryptococcus neoformans is a facultative intracellular pathogen responsible for the most common cause of fungal meningioencephalitis, occurring primarily in immunocompromised individuals. Antiphagocytic protein 1 (App1) is a virulence factor produced by C. neoformans that inhibits phagocytosis of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghaffar, Muhammad, Orr, Cody, Webb, Ginny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892493/ https://www.ncbi.nlm.nih.gov/pubmed/31800598 http://dx.doi.org/10.1371/journal.pone.0225701

Ejemplares similares

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

Combined effect of furanone fluconazole and amphotericin B against biofilms formed from Cryptococcus neoformans
por: Meenakumari, Kirishnamoorthy, et al.
Publicado: (2021)

Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans
por: Rizzo, Juliana, et al.
Publicado: (2023)

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans
por: Movahed, Elaheh, et al.
Publicado: (2016)

The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
por: Hai, Trieu Phan, et al.
Publicado: (2019)

The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans
por: Momin, Mahek, et al.
Publicado: (2021)

De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans
por: Banerjee, Dithi, et al.
Publicado: (2016)

Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans
por: Bhattacharya, Somanon, et al.
Publicado: (2021)

Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans
por: Dbouk, Nadir Hani, et al.
Publicado: (2019)

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade
por: Naicker, Serisha D., et al.
Publicado: (2020)

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study
por: Chen, Yi-Chun, et al.
Publicado: (2015)

Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro
por: Peng, Congyue Annie, et al.
Publicado: (2018)

Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans
por: Oliveira, Natalia Kronbauer, et al.
Publicado: (2022)

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans
por: Andriani, Gabriella Maria, et al.
Publicado: (2023)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Colony and Single Cell Level Analysis of the Heterogeneous Response of Cryptococcus neoformans to Fluconazole
por: Altamirano, Sophie, et al.
Publicado: (2018)

Necrotizing fasciitis as the initial presentation of disseminated infection with fluconazole-resistant Cryptococcus neoformans
por: Richardson, Timothy E, et al.
Publicado: (2014)

Correction for Banerjee et al., “De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans”
por: Banerjee, Dithi, et al.
Publicado: (2023)

Lack of Association between Fluconazole Susceptibility and ERG11 Nucleotide Polymorphisms in Cryptococcus neoformans Clinical Isolates from Uganda
por: Atim, Priscilla Belbir, et al.
Publicado: (2022)

Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans
por: Ngamskulrungroj, Popchai, et al.
Publicado: (2012)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
por: Fay, Vanessa da Silva, et al.
Publicado: (2018)

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates
por: de Aquino Lemos, Janine, et al.
Publicado: (2009)

Mutants with heteroresistance to amphotericin B and fluconazole in Candida
por: Claudino, A.L.R., et al.
Publicado: (2009)

Antifungal efficacy of amphotericin B encapsulated fibrin microsphere for treating Cryptococcus neoformans infection in Swiss albino mice
por: Khan, Azmat Ali, et al.
Publicado: (2016)

Minocycline and Fluconazole Have a Synergistic Effect Against Cryptococcus neoformans Both in vitro and in vivo
por: Kong, Qinxiang, et al.
Publicado: (2020)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations
por: Melendres, Javier, et al.
Publicado: (2022)

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan
por: Yang, Yun-Liang, et al.
Publicado: (2005)

Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A
por: Florio, Ada Rita, et al.
Publicado: (2011)

Fluconazole-Induced Ploidy Change in Cryptococcus neoformans Results from the Uncoupling of Cell Growth and Nuclear Division
por: Altamirano, Sophie, et al.
Publicado: (2017)

High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the Cryptococcus neoformans Complex in Jiangxi Province, South Central China
por: Yang, Chunxi, et al.
Publicado: (2021)

Melaninization Reduces Cryptococcus neoformans Susceptibility to Mechanical Stress
por: Mattoon, Ellie Rose, et al.
Publicado: (2023)

Carbon Dioxide Potentiates Flucytosine Susceptibility in Cryptococcus neoformans
por: Jezewski, Andrew J., et al.
Publicado: (2023)

Application of caspofungin in China compared with amphotericin B and fluconazole
por: Zhang, Chunyu, et al.
Publicado: (2014)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2021)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m61i5n23fltorl1mprvof9dkkm